Fast Market Research

Global Heparin Market 2016-2020 - New Market Report

Fast Market Research announces the availability of the new TechNavio report, "Global Heparin Market 2016-2020", on their comprehensive research portal

 

Boston, MA -- (SBWIRE) -- 03/31/2016 -- Heparin, a disaccharide anticoagulant or blood thinner, prevents the formation of blood clots. It is produced in the body by basophils and mast cells. It is stored within mast cells and secreted at the injury site. Though it has no effect on already formed clots, it enables the body's natural clot lysis mechanisms to dissolve clots. It can also be taken from outside as a drug. Heparin can be derived from natural sources such as pig intestine and bovine lungs.
Heparin is divided into two types based on the fractionation process. Both types have medical use, with the selection done based on preference for a particular condition.

-UFH: It is directly obtained from natural sources, without undergoing any fractionation.
-LMWH: It is derived by depolymerizing UFH. The pharmacodynamics properties of LMWH are more predictable when compared to UFH.

Get More Details on this Report and a Full Table of Contents at Global Heparin Market 2016-2020

Apart from these, another category of molecules, ULMWH are available. They are structurally related to LMWHs, but differ in the composition of monosaccharides and oligosaccharides. Therefore, they have different average molecular weights from LMWH.

Technavio's analysts forecast the global heparin market to grow at a CAGR of 4.74% during the period 2016-2020.

Covered in this report
The report covers the present scenario and the growth prospects of the global heparin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generics used to treat disorders.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Heparin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-GlaxoSmithKline plc (GSK)
-Leo Pharma A/S
-Pfizer Inc.
-Sanofi

Other prominent vendors

-Alchemi
-Baxter
-BMS
-Boehringer Ingelheim
-Celgene
-Cosmo Pharmaceuticals
-Dr.Reddy's Laboratories
-Eisai
-Fresenius
-GSK
-Hospira
-Laboratorios Rovi Pharmaceuticals
-Lee's Pharmaceutical
-Momenta Pharmaceuticals
-Mylan
-Novartis
-Ockham Biotech
-Perospher
-PolyMedix
-Portola Pharmaceutical
-ProStrakan Group
-Sagent Pharmaceticals
-Sigma Tau Pharmaceuticals
-UCB
-Urigen Pharmaceuticals

Market driver

-Growing prevalence of diseases
-For a full, detailed list, view our report

Market challenge

-Extensive use of generic products due to patent expirations
-For a full, detailed list, view our report

Market trend

-Expected exploitation of new therapeutic use
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2020 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: GlaxoSmithKline plc (GSK), Leo Pharma A/S, Pfizer Inc., Sanofi, Alchemi, Baxter, BMS, Boehringer Ingelheim, Celgene, Cosmo Pharmaceuticals, Dr.Reddy's Laboratories, Eisai, Fresenius, GSK, Hospira, Laboratorios Rovi Pharmaceuticals, Lee's Pharmaceutical, Momenta Pharmaceuticals, Mylan, Novartis, Ockham Biotech, Perospher, PolyMedix, Portola Pharmaceutical, ProStrakan Group, Sagent Pharmaceticals, Sigma Tau Pharmaceuticals, UCB, Urigen Pharmaceuticals

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Global Heparin Market 2015-2019
-Global Pharmacy Information System Market - Global Forecast to 2019
-Partnerships, Licensing, Investments and M&A Deals and Trends for November 2015 in Pharmaceuticals
-Partnerships, Licensing, Investments and M&A Deals and Trends for September 2015 in Pharmaceuticals
-Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2015